Analytical performance of the N terminal pro B type natriuretic peptide (NT‐proBNP) assay on the Elecsys™ 1010 and 2010 analysers

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Journal of Heart Failure

• Publication date

  2004-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejheart.2004.01.011PMID 14987590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment

  1997cited by this paper
• Preliminary evaluation of an

  1993cited by this paper

• Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure: a prospective cohort study in Vietnam

  2025influential citation
• Association of cardiac biomarkers with long-term cardiovascular events in a community cohort

  2024cites this paper
• Quantifying Hemodynamic Cardiac Stress and Cardiomyocyte Injury in Normotensive and Hypertensive Acute Heart Failure

  2024influential citation
• Intrarenal Venous Flow Pattern Changes Do Relate With Renal Function Alterations in Acute Heart Failure.

  2023cites this paper
• Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial

  2023cites this paper
• Quantifying inflammation using interleukin‐6 for improved phenotyping and risk stratification in acute heart failure

  2023cites this paper
• Ultrasensitive and Rapid Detection of N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Using Fiber Optic Nanogold-Linked Immunosorbent Assay

  2022cites this paper
• Utility of plasma CA125 as a proxy of intra-abdominal pressure in patients with acute heart failure.

  2022cites this paper
• Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction

  2022cites this paper
• CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure.

  2021cites this paper
• Association between N-terminal pro-BNP and 12 months major adverse cardiac events among patients admitted with NSTEMI.

  2021cites this paper
• Impact of an endurance training program on exercise-induced cardiac biomarker release endurance training exercise-induced

  2021cites this paper
• Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure.

  2021cites this paper
• Cardiac myosin‐binding protein C in the diagnosis and risk stratification of acute heart failure

  2021cites this paper
• Effect of feline characteristics on plasma N‐terminal‐prohormone B‐type natriuretic peptide concentration and comparison of a point‐of‐care test and an ELISA test

  2020cites this paper
• A chemiluminescence immunoassay for the detection of NT-proBNP.

  2020cites this paper
• Impact of an endurance training program on exercise-induced cardiac biomarker release an endurance training program on exercise-induced release. OF LJMU Research Online

  2019cites this paper
• The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study

  2019cites this paper
• N-terminal pro-brain natriuretic peptide: a potential follow-up biomarker of mandibular advancement device efficacy on

  2019cites this paper
• Successful Management of Pulmonary Arterial Hypertension by Monitoring N-Terminal Pro-B-Type Natriuretic Peptide Serum Levels in a Preterm Infant with Chronic Lung Disease: A Case Report

  2019cites this paper
• Evaluation of “point of care” brain natriuretic peptide level in differentiating between cardiogenic and noncardiogenic acute dyspnea (a hospital-based study)

  2019cites this paper
• Role of B-type natriuretic peptide level in predicting future cardiac events in patients presenting with dyspnea (a hospital-based study)

  2019cites this paper
• External Validation of the MEESSI Acute Heart Failure Risk Score

  2019cites this paper
• Clinical evaluation of capillary B-type natriuretic peptide testing

  2019cites this paper
• N-terminal pro-brain natriuretic peptide: a potential follow-up biomarker of mandibular advancement device efficacy on cardiac function in obstructive sleep apnea.

  2018cites this paper
• Sex‐specific associations of obesity and N‐terminal pro‐B‐type natriuretic peptide levels in the general population

  2018cites this paper
• Running head: Endurance training and cardiac biomarker Corresponding author

  2018cites this paper
• N-terminal pro-brain natriuretic peptide: a potential follow-up biomarker of mandibular advancement device efficacy on cardiac function in obstructive sleep apnea

  2018cites this paper
• Quantum dot enabled lateral flow immunoassay for detection of cardiac biomarker NT-proBNP

  2018cites this paper
• Cardiac Biomarker Release after Endurance Exercise in Male and Female Adults and Adolescents

  2017cites this paper
• Investigation of an N‐Terminal Prohormone of Brain Natriuretic Peptide Point‐of‐Care ELISA in Clinically Normal Cats and Cats With Cardiac Disease

  2017cites this paper
• University of Groningen BNP and NT-proBNP in heart failure

  2017cites this paper
• Human heart failure biomarker immunosensor based on excessively tilted fiber gratings.

  2017cites this paper
• A novel strategy for rapid detection of NT-proBNP

  2017cites this paper
• NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk.

  2017cites this paper
• Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension.

  2017cites this paper
• Relationship between maternal hemodynamics and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia and fetal growth restriction

  2017cites this paper
• Prognostic utility of combination of NT-proBNP with high sensitive cTn I in patients with heart failure: Results from retrospective study in an emergency department

  2016cites this paper
• Positive Response to Cardiac Resynchronization Therapy: The Role of NT-proBNP

  2016cites this paper
• Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender

  2016cites this paper
• Impact of an endurance training program on exercise-induced cardiac biomarker release.

  2015cites this paper
• Timing of Dynamic NT-proBNP and hs-cTnT Response to Exercise Challenge in Asymptomatic Children with Moderate Aortic Valve Regurgitation or Moderate Aortic Valve Stenosis

  2015cites this paper
• Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study.

  2015cites this paper
• Heart failure in elderly with focus on diagnosis and prognosis

  2015cites this paper
• Comparison of new point-of-care troponin assay with high sensitivity troponin in diagnosing myocardial infarction.

  2014cites this paper
• Quantitative, noninvasive assessment of patent ductus arteriosus shunt flow by measuring proximal isovelocity surface area on color Doppler imaging.

  2014cites this paper
• High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general population.

  2014cites this paper
• An antibody reactive to the Gly63–Lys68 epitope of NT-proBNP exhibits O-glycosylation-independent binding

  2014cites this paper
• Development of competition ELISA for N-terminal fragment of proBNP (NT-proBNP) using peptide mimotope and bispecific antibody against NT-proBNP and cotinine

  2014cites this paper
• New onset heart failure: origin and manifestation

  2014cites this paper
• NTproBNP: an important biomarker in cardiac diseases.

  2013cites this paper
• ANALISIS PROTEOMICO EN PLASMA DE PACIENTES CON EVENTOS CORONARIOS AGUDOS

  2013cites this paper
• Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.

  2013cites this paper
• NT-proBNP correlated with strain and strain rate imaging of the right ventricle before and after transcatheter closure of atrial septal defects.

  2013cites this paper
• Defining high-sensitivity cardiac troponin concentrations in the community.

  2013cites this paper
• Circulating fragments of N-terminal pro-B-type natriuretic peptides in plasma of heart failure patients.

  2013cites this paper
• Diagnostic value of NT-proBNP in identifying impaired coronary flow reserve in asymptomatic moderate or severe aortic stenosis.

  2013cites this paper
• B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease

  2013cites this paper
• Comparison of immunoassays for NTproBNP conducted on three analysis systems: Milliplex, Elecsys and RIA.

  2013cites this paper
• Novel Management of Heart Failure

  2013cites this paper
• N-terminal pro-brain natriuretic peptide as a predictor of cardiovascular events and mortality in patients with differentiated thyroid carcinoma

  2013cites this paper
• Multicentre evaluation of a second generation point-of-care assay with an extended range for the determination of N-terminal pro-brain natriuretic peptide.

  2012cites this paper
• Die Beurteilung der Belastungstoleranz des geschädigten Myokards anhand von Biomarkern

  2012cites this paper
• Effects of interventions in the RAAS and sodium status on classical and non-classical outcome parameters in chronic kidney disease

  2012cites this paper
• Baseline and post-exercise N-terminal pro-B-type natriuretic peptide values are associated with body mass index.

  2012cites this paper
• Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients.

  2012cites this paper
• Diagnostic power of the mid-regional pro-atrial natriuretic peptide for heart failure patients with dyspnea: a meta-analysis.

  2012cites this paper
• Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population

  2012cites this paper
• The novel marker LTBP2 predicts all-cause and pulmonary death in patients with acute dyspnoea.

  2012cites this paper
• Cardiac Biomarker Response to Intermittent Exercise Bouts

  2011cites this paper
• Selective association of endogenous ouabain with subclinical organ damage in treated hypertensive patients

  2011cites this paper
• Volume overload and pressure overload due to left-to-right shunt-induced myocardial injury. - Evaluation using a highly sensitive cardiac Troponin-I assay in children with congenital heart disease-.

  2011cites this paper
• Effects of Mono- and Dual Blockade of the Renin-Angiotensin System on Markers of Cardiovascular Status in Hypertensive Patients with Mild and Moderate Renal Failure

  2011influential citation
• Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study.

  2011cites this paper
• Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction

  2011cites this paper
• N-Terminal Pro-Brain Natriuretic Peptide: A Powerful Predictor of Mortality in Hypertension

  2011cites this paper
• BNP and NT-proBNP in cardiovascular disease

  2011cites this paper
• Overload and Pressure Overload due to Left-to-Right Shunt-Induced Myocardial Injury – Evaluation Using a Highly Sensitive Cardiac Troponin-I Assay in Children With Congenital Heart Disease –

  2011cites this paper
• N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population.

  2010cites this paper
• Interleukin family member ST2 and mortality in acute dyspnoea

  2010cites this paper
• Novel Echocardiographic Techniques in the Diagnosis of Heart Failure

  2010cites this paper
• Multicentre analytical evaluation of a new point-of-care system for the determination of cardiac and thromboembolic markers.

  2010cites this paper
• Diagnostic Equivalence of an N-terminal Pro-brain Natriuretic Peptide Point-of-care Test to the Laboratory Method in Patients With Heart Failure and in Reference Populations

  2010cites this paper
• The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects.

  2010cites this paper
• The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. - Correlation with the heart failure score and comparison with B-type natriuretic peptide -.

  2010cites this paper
• Increase in N-terminal fragment of the prohormone brain-type natriuretic peptide as a measure for predicting outcome after urgent heart transplantation.

  2010cites this paper
• Copeptin and risk stratification in patients with acute dyspnea

  2010influential citation
• Amino-terminal pro-brain natriuretic peptide (NT-proBNP) is a biomarker of cardiac filling pressures in pre-eclampsia.

  2010cites this paper
• Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA)

  2010cites this paper
• Novel Echocardiographic Techniques in the Diagnosis of Heart Failure

  2010cites this paper
• [Long-term prognosis of serum and urine n-terminal proBNP levels and glomerular filtration rate in heart failure patients].

  2010cites this paper
• Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study

  2009cites this paper
• Prevalence, risk factors and detection of left ventriclar dysfunction in the community : Canberra heart study

  2009cites this paper
• The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study.

  2009cites this paper
• Midregional pro-Adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study

  2009cites this paper
• [NT-proBNP in practice: from chemistry to medicine].

  2009cites this paper
• A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study

  2009cites this paper
• [NT-proBNP in practice: from chemistry to medicine].

  2009cites this paper
• Urinary N-Terminal Prohormone Brain Natriuretic Peptide Excretion in Patients With Chronic Heart Failure

  2009cites this paper
• NT-proBNP en pratique « De la biologie à la clinique »

  2009cites this paper